Ohcanbohtosat - Christopher Brittain

  • Čájehuvvo 1 - 10 / 10
Aiddostahte ozu
  1. 1
    Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade

    Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade Dahkki Anthony P. Adamis, Christopher Brittain, Atul Dandekar, J. Jill Hopkins

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET

    THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET Dahkki David S. Boyer, Ursula Schmidt‐Erfurth, Menno van Lookeren Campagne, Erin C. Henry, Christopher Brittain

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

    CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION Dahkki Srinivas R. Sadda, Usha Chakravarthy, David G. Birch, Giovanni Staurenghi, Erin C. Henry, Christopher Brittain

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

    The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration Dahkki Monika Fleckenstein, Paul Mitchell, K. Bailey Freund, Srinivas R. Sadda, Frank G. Holz, Christopher Brittain, Erin C. Henry, Daniela Ferrara

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

    Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration Dahkki Usha Chakravarthy, Clare Bailey, Robert L. Johnston, Martin McKibbin, Rehna Khan, Sajjad Mahmood, Louise Downey, Narendra Dhingra, Christopher Brand, Christopher Brittain, Jeffrey R. Willis, Sarah Rabhi, Anushini Muthutantri, Ronald A. Cantrell

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration

    Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Dahkki Frank G. Holz, Srinivas R. Sadda, Brandon Busbee, Emily Y. Chew, Paul Mitchell, Adnan Tufail, Christopher Brittain, Daniela Ferrara, Sarah Gray, Lee Honigberg, Jillian Martin, Barbara Tong, Jason S. Ehrlich, Neil M. Bressler

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors

    Progression from Early/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors Dahkki Usha Chakravarthy, Clare Bailey, Peter H. Scanlon, Martin McKibbin, Rehna Khan, Sajjad Mahmood, Louise Downey, Narendra Dhingra, Christopher Brand, Christopher Brittain, Jeffrey R. Willis, Alessandra Venerus, Anushini Muthutantri, Ronald A. Cantrell

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

    Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study Dahkki Adnan Tufail, Praveen J. Patel, Sobha Sivaprasad, Winfried M. K. Amoaku, Andrew C. Browning, Michael D. Cole, Richard Gale, Sheena George, Andrew Lotery, M. A. Majid, Martin McKibbin, Geeta Menon, Yit C. Yang, C. Andrews, Christopher Brittain, Aaron Osborne

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion

    Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion Dahkki Ramin Tadayoni, Liliana P Paris, Carl J. Danzig, Francis Abreu, Arshad M. Khanani, Christopher Brittain, Timothy Y. Y. Lai, Zdenka Hašková, Taiji Sakamoto, Aachal Kotecha, Patricio G. Schlottmann, Ying Liu, András Seres, Anne-Cecile Retiere, Jeffrey R. Willis, Young Hee Yoon

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked... Dahkki Jeffrey S. Heier, Arshad M. Khanani, Carlos Quezada-Ruiz, Karen Basu, Philip J. Ferrone, Christopher Brittain, Marta S. Figueroa, Hugh Lin, Frank G. Holz, Vaibhavi Patel, Timothy Y. Y. Lai, David G. Silverman, Carl D. Regillo, Balakumar Swaminathan, Francesco Viola, Chui Ming Gemmy Cheung, Tien Yin Wong, Ashkan M. Abbey, Elmira Abdulaeva, Prema Abraham, Alfredo Adán, Hansjürgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement K. Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Chui Ming Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell, Nicholas Fung, Federico Furno Sola, Richard Gale

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: